Skip to content

Gelsoft Plus™ 634008PRecalls & reported problems

Vascutek Ltd · Gelsoft Plus Gelatin Impregnated Knitted Vascular Prosthesis STRAIGHT · Class 2 · Implant

All models of Gelsoft Plus (19)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05037881115191), received between Jun 29, 2023 and Jun 29, 2023 — classified as 1 injury.

1 other recall cover devices cleared under the same FDA submission (K162803, K955230); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Seroma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 29, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    GELSOFT PLUS STRAIGHT WAS IMPLANTED ON (B)(6) 2023. 2 DAYS POST-OP THE PATIENT CAME TO THE HOSPITAL WITH RED AND HOT SKIN AT THE AREA BETWEEN THE ANASTOMOSIS. THE TWO SUTURES OF THE UPPER AND LOWER ANASTOMOSIS WERE UNREMARKABLE. STRONG PAIN ( MEDICALLY TREATED). ANTIBIOTIC THERAPY STARTED: LEUKOCYTES DOWN, CRP CONSTANT. ULTRASOUND WITH NO FINDINGS, CT SCAN: FLUID AROUND THE IMPLANT AND SWOLLEN LYMPH NODES. MICROBIOLOGY WITHOUT FINDINGS. GRAFT WAS EXPLANTED ON (B)(6) 2023 THE FOLLOWING WAS NOTICED DURING EXPLANT PROCEDURE: CLOUDY ACCUMULATION OF FLUID, IN THE AREA OF THE DIST. ANASTOMOSIS SIGNIFICANTLY MORE. WHITE STRUCTURES ( FIBRIN ). PROSTHESIS EXPLANTED, MICROBIOLOGICAL SWAB TAKEN BY PROXIMAL AND DISTAL ANASTOMOTIC AREA, SHORT PART OF PROXIMAL PROSTHESIS SENT TO MICROBIOLOGY AND THE REST IS SENT BACK TO TERUMO AORTIC (NOT RECEIVED BY TERUMO AORTIC YET) NEW BYPASS WITH ONIFLOW PROSTHESIS IMPLANTED. ADDITIONAL INFORMATION RECEIVED ON 05.06.2023: THE INTRAOPERATIVE WOUND SWAB IS NEGATIVE, NO PATHOGENS DETECTABLE. THE SYMPTOMS WERE SIGNIFICANTLY REDUCED THE DAY AFTER THE EXPLANT. THIS REPORT HAS BEEN SUBMITTED AS FOLLOW UP 1 FOR MFG. REPORT FDA 9612515-2023-00004 TO PROVIDE CORRECTI

    Patient problems: Seroma

    MAUDE report 17223849 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K162803, K955230. One submission often covers many models, so check the product and lot details in each record.

  • Z-2542-2021 · Jul 8, 2021 · Terminated
    The Instructions for Use (IFU) for: Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem, Gelweave Straight, Gelweave Trifurcate, Gelweave Ant-Flo, and Gelweave Val

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page